These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 2110909)
1. Inhibition of human granulocyte-macrophage colony formation by interleukin 2-treated lymphocytes is mediated by interferon gamma and tumor necrosis factor alpha. Takahashi M; Oshimi K; Mizoguchi H Exp Hematol; 1990 Jun; 18(5):395-9. PubMed ID: 2110909 [TBL] [Abstract][Full Text] [Related]
2. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma. Papadakis V; Ferguson KF; Heller G; Kernan NA Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927 [TBL] [Abstract][Full Text] [Related]
3. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma. Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433 [TBL] [Abstract][Full Text] [Related]
4. Recombinant human tumor necrosis factors alpha and beta stimulate fibroblasts to produce hemopoietic growth factors in vitro. Zucali JR; Broxmeyer HE; Gross MA; Dinarello CA J Immunol; 1988 Feb; 140(3):840-4. PubMed ID: 3276782 [TBL] [Abstract][Full Text] [Related]
5. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy. Pak AS; Ip G; Wright MA; Young MR Cancer Res; 1995 Feb; 55(4):885-90. PubMed ID: 7850804 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of suppression of normal hemopoietic activity by lymphokine-activated killer cells and their products. Gibson FM; Malkovska V; Myint AA; Meager A; Gordon-Smith EC Exp Hematol; 1991 Aug; 19(7):659-63. PubMed ID: 1909968 [TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development. Wang CQ; Udupa KB; Lipschitz DA J Cell Physiol; 1995 Jan; 162(1):134-8. PubMed ID: 7814445 [TBL] [Abstract][Full Text] [Related]
8. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells. Ferret-Bernard S; Saï P; Bach JM Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293 [TBL] [Abstract][Full Text] [Related]
9. The influence of the supernatant obtained from a culture of IL-2-activated lymphocytes on human hematopoietic progenitors. Iizuka Y; Endo M; Horikoshi A; Takeuchi J; Ohshima T Exp Hematol; 1990 Feb; 18(2):119-23. PubMed ID: 1689247 [TBL] [Abstract][Full Text] [Related]
10. OKT3 monoclonal antibody induces production of colony-stimulating factor(s) for granulocytes and macrophages in cultures of human T lymphocytes and adherent cells. Platzer E; Rubin BY; Lu L; Welte K; Broxmeyer HE; Moore MA J Immunol; 1985 Jan; 134(1):265-71. PubMed ID: 3917276 [TBL] [Abstract][Full Text] [Related]
11. Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation of enriched hematopoietic precursor cells. Murphy M; Perussia B; Trinchieri G Exp Hematol; 1988 Feb; 16(2):131-8. PubMed ID: 3123270 [TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. Broxmeyer HE; Lu L; Platzer E; Feit C; Juliano L; Rubin BY J Immunol; 1983 Sep; 131(3):1300-5. PubMed ID: 6193183 [TBL] [Abstract][Full Text] [Related]
13. Suppressive biological activity of a synthetic pentapeptide on highly enriched human and murine marrow hematopoietic progenitors: synergism with recombinant human tumor necrosis factor-alpha and interferon-gamma. Lu L; Foa P; Chillemi F; Shen RN; Lin ZH; Carow C; Broxmeyer HE Exp Hematol; 1989 Oct; 17(9):935-41. PubMed ID: 2506072 [TBL] [Abstract][Full Text] [Related]
14. Receptor-specific modulation of myelopoiesis by recombinant DNA-derived interleukin 2. Burdach S; Shatsky M; Wagenhorst B; Levitt L J Immunol; 1987 Jul; 139(2):452-8. PubMed ID: 3110272 [TBL] [Abstract][Full Text] [Related]
15. The synergistic influence of human interferon-gamma and interferon-alpha on suppression of hematopoietic progenitor cells is additive with the enhanced sensitivity of these cells to inhibition by interferons at low oxygen tension in vitro. Broxmeyer HE; Cooper S; Rubin BY; Taylor MW J Immunol; 1985 Oct; 135(4):2502-6. PubMed ID: 3928752 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of release of granulocyte- and granulocyte-macrophage colony-stimulating factors from phytohemagglutinin-stimulated sorted subsets of human T lymphocytes by recombinant human tumor necrosis factor-alpha. Synergism with recombinant human IFN-gamma. Lu L; Srour EF; Warren DJ; Walker D; Graham CD; Walker EB; Jansen J; Broxmeyer HE J Immunol; 1988 Jul; 141(1):201-7. PubMed ID: 2454257 [TBL] [Abstract][Full Text] [Related]
17. Synergistic inhibition of human marrow granulocyte-macrophage progenitor cells by prostaglandin E and recombinant interferon-alpha, -beta, and -gamma and an effect mediated by tumor necrosis factor. Pelus LM; Ottmann OG; Nocka KH J Immunol; 1988 Jan; 140(2):479-84. PubMed ID: 3121745 [TBL] [Abstract][Full Text] [Related]
19. Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions. Broxmeyer HE; Lu L; Cooper S; Tushinski R; Mochizuki D; Rubin BY; Gillis S; Williams DE J Immunol; 1988 Dec; 141(11):3852-62. PubMed ID: 3053902 [TBL] [Abstract][Full Text] [Related]